You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Splenomegaly

Showing 26 - 50 of 707
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ruxolitinib in Patients With Myelofibrosis

Not yet recruiting
  • Myelofibrosis
  • (no location specified)
Feb 28, 2023

Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 1, 2022

Polycythemia Vera Trial in Worldwide (Idasanutlin)

Terminated
Has Results
  • Polycythemia Vera
  • Phoenix, Arizona
  • +10 more
Dec 7, 2021

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)

Active, not recruiting
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 20, 2022

Clinical Characteristics and Long-term Outcomes of Brucellosis

Completed
  • Brucellosis
    • Huanggang, Hu Bei Province, China
    • +7 more
    Aug 17, 2023

    Esophageal Varices Trial (Detailed abdominal ultrasound)

    Not yet recruiting
    • Esophageal Varices
    • Detailed abdominal ultrasound
    • (no location specified)
    Mar 12, 2023

    Bone Denisty Change in Children With Beta Thalassemia Major

    Not yet recruiting
    • Evaluate Bone Denisty Changes in Children With Beta Thalassemia Major
    • Dexa scan
    • (no location specified)
    Sep 29, 2023

    Quality of Life in Thalassemic Patients at Assiut University

    Not yet recruiting
    • Thalassemia
    • Abdominal ultrasound
    • (no location specified)
    Mar 17, 2023

    Natural History of Noncirrhotic Portal Hypertension

    Recruiting
    • Cystic Fibrosis
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Sep 27, 2022

      Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

      Completed
      • Adherence, Patient
      • Adherence, Treatment
        • Cosenza, Calabria, Italy
        • +27 more
        Oct 11, 2023

        Relapsed Chronic Lymphocytic Leukemia Trial in Ann Arbor (Metformin)

        Recruiting
        • Relapsed Chronic Lymphocytic Leukemia
        • Ann Arbor, Michigan
          University of Michigan Comprehensive Cancer Center
        May 11, 2022

        Children and Adult Hemophagocytic Syndrome (HLHa)

        Completed
        • Hemophagocytic Syndrome
        • Identification of biological markers
        • Paris, France
          Clinical Research Unit
        Nov 19, 2021

        Multimodal Ultrasound and Portal Hypertension

        Recruiting
        • Portal Hypertension
          • Roma, Italy
            Fondazione Policlinico Gemelli IRCCS
          Mar 16, 2023

          Substances Potentially Indicating Bone Problems in Type 1

          Not yet recruiting
          • Gaucher Disease
          • No Intervention
          • Zaragoza, Aragon, Spain
            Fundación Española para el Estudio y Tratamiento de la Enfermeda
          Jan 18, 2023

          Liver Cirrhosis, Portal Hypertension, Ascites Trial in Vienna

          Recruiting
          • Liver Cirrhosis
          • +4 more
            • Vienna, Austria
              Medical University of Vienna
            Oct 9, 2022

            Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

            Recruiting
            • Myelofibrosis
            • Saint Louis, Missouri
              Washington University School of Medicine
            Oct 26, 2022

            CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

            Terminated
            Has Results
            • CLL
            • SLL
            • Boston, Massachusetts
            • +1 more
            Jan 30, 2023

            Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

            Recruiting
            • Secondary Hemophagocytic Lymphohistiocytosis
            • Chronic Active Epstein-Barr Virus Infection
            • No intervention
            • Beijing, Beijing, China
              Beijing Friendship Hospital, Capital Medical University
            May 2, 2023

            Glycogen Storage Disease Type IB Trial in Shanghai (Empagliflozin)

            Recruiting
            • Glycogen Storage Disease Type IB
            • Shanghai, Shanghai, China
              Xinhua Hospital, Shanghai Jiao Tong University School of Medicin
            Jul 17, 2023

            Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

            Recruiting
            • Essential Thrombocytopenia
            • Recombinant Interferon Alpha
            • Pegylated interferon alfa-2b
            • Tianjin, Tianjin, China
              Institute of Hematology & Blood Diseases Hospital
            Jul 18, 2022

            Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)

            Recruiting
            • Myeloproliferative Neoplasm
            • +2 more
            • Fedratinib Pill
            • Tampa, Florida
              Moffitt Cancer Center
            Jun 15, 2022

            MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

            Recruiting
            • Myelodysplastic Syndromes
            • Myeloproliferative Chronic Myelomonocytic Leukemia
            • Houston, Texas
              M D Anderson Cancer Center
            Oct 31, 2022

            B-Cell Non-Hodgkin Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma Trial in Palo Alto (biological, other,

            Active, not recruiting
            • B-Cell Non-Hodgkin Lymphoma
            • +7 more
            • Anti-OX40 Antibody BMS 986178
            • +3 more
            • Palo Alto, California
              Stanford University, School of Medicine
            May 3, 2022

            Adult-Onset Still's Disease, AOSD Trial in Moscow, St. Petersburg (RPH-104, Placebo)

            Not yet recruiting
            • Adult-Onset Still's Disease
            • AOSD
            • RPH-104
            • Placebo
            • Moscow, Russian Federation
            • +3 more
            Jun 21, 2022